Not applicableUnknownNCT00852501What this trial is testingCharacterization of Receptors in Non-functioning Pituitary MacroadenomasWho this might be right forPituitary Tumor Cook County Health 100
Not applicableStudy completedNCT02385747What this trial is testingUterine Cavity Assessment and Endometrial Hormonal Receptors in Women With Peri and Post Menopausal BleedingWho this might be right forVaginal Bleeding Cairo University 100
Large-scale testing (Phase 3)Looking for participantsNCT06781996What this trial is testingDetermine the Efficacy of a Digital Self-management Support Tool to Improve the Quality of Life During Adjuvant HOrmonal Therapy for Patients With Early Breast CancerWho this might be right forBreast CancerBreast Cancer Early Stage Breast Cancer (Stage 1-3) Gustave Roussy, Cancer Campus, Grand Paris 180
Testing effectiveness (Phase 2)Study completedNCT00365599What this trial is testingPhase II Trial of SAHA & Tamoxifen for Patients With Breast CancerWho this might be right forBreast Cancer H. Lee Moffitt Cancer Center and Research Institute 43
Not applicableUnknownNCT03489473What this trial is testingFESPET Study: Female EStrogen recePtor in Endometrial Cancer TreatmentWho this might be right forEndometrial Cancer Radboud University Medical Center 40
Early research (Phase 1)Study completedNCT04080297What this trial is testingDose Escalation Study in Female Subjects With Breast Cancer Receiving Aromatase Inhibitor or TamoxifenWho this might be right forVasomotor Symptoms (VMS) Que Oncology 21
Early research (Phase 1)Study completedNCT03099174What this trial is testingThis Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast CancerWho this might be right forNeoplasmsBreast Neoplasms Boehringer Ingelheim 133
Large-scale testing (Phase 3)Study completedNCT02941926What this trial is testingStudy to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBCWho this might be right forBreast Cancer Novartis Pharmaceuticals 3,246
Not applicableUnknownNCT06278103What this trial is testingCorrelation Between Expression of Hormonal Receptors, Clinical Data, and Methylation Profile in Meningiomas (MethylRH-M)Who this might be right forMeningioma Central Hospital, Nancy, France 180
Not applicableStudy completedNCT01635062What this trial is testingThe VALIDATE-D StudyWho this might be right forType 2 DiabetesObesity Brigham and Women's Hospital 41
Not applicableStudy completedNCT05377684What this trial is testingStudy of Quality of Life and Hormone Levels in Premenopausal Participants With Early Breast Cancer Receiving Triptorelin Plus Additional Cancer TreatmentWho this might be right forEarly-stage Breast Cancer Ipsen 450
Testing effectiveness (Phase 2)Study completedNCT03839823What this trial is testingStudy to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal Patients With Advanced or Metastatic Breast CancerWho this might be right forBreast Cancer Novartis Pharmaceuticals 222
Testing effectiveness (Phase 2)Temporarily pausedNCT00738777What this trial is testingPre-operative Hormonal Treatment for Hormone Receptor Positive Breast CancerWho this might be right forBreast Cancer The Netherlands Cancer Institute 250
Not applicableUnknownNCT05814224What this trial is testingMonitoring luminAl Breast Cancer Through the Evaluation of Mutational and epiGeNEtic alteraTIons of Circulating ESR1 DNAWho this might be right forHormone Receptor Positive Breast CarcinomaBreast NeoplasmsNeoplasms, Breast+4 more Centro di Riferimento Oncologico - Aviano 164
Large-scale testing (Phase 3)Ended earlyNCT00925548What this trial is testingSTRIDE - STimulating Immune Response In aDvanced brEast CancerWho this might be right forBreast Cancer EMD Serono 16
Large-scale testing (Phase 3)Ended earlyNCT00097344What this trial is testingThe CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast CancerWho this might be right forBreast NeoplasmsNeoplasms, Hormone-Dependent Intarcia Therapeutics 842
Large-scale testing (Phase 3)Ended earlyNCT00684216What this trial is testingSecond-line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment in Patients With Metastatic ER Positive Breast CancerWho this might be right forBreast Cancer The Netherlands Cancer Institute 10
Post-approval studies (Phase 4)Not Yet RecruitingNCT07462663What this trial is testingSHAPE-ENDO: Pilot Randomized Trial of Multimodal Pre-Surgical Optimization Versus Standard Surgery in Patients With Obesity and Early-Stage Endometrial CancerWho this might be right forEndometrial CancerEndometrial Cancer Stage IAtypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I+6 more Hospital Universitari de Bellvitge 80
Not applicableStudy completedNCT01738152What this trial is testingNon-Hormonal Vaginal Moisturizer in Hormone-Receptor Positive Postmenopausal Cancer Survivors Experiencing Estrogen Deprivation Symptoms on Vulvovaginal HealthWho this might be right forBreast CancerEndometrial Cancer Memorial Sloan Kettering Cancer Center 106
Early research (Phase 1)Active Not RecruitingNCT01327781What this trial is testingZ-Endoxifen Hydrochloride in Treating Patients With Metastatic or Locally Recurrent Estrogen Receptor-Positive Breast CancerWho this might be right forHER2/Neu PositiveRecurrent Breast CarcinomaStage IIIC Breast Cancer AJCC v7+1 more National Cancer Institute (NCI) 62